Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -8.46%. However, over the past six months, we’ve seen
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Until today this year the stock’s price performance
The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Lineage Cell Therapeutics Inc’s current trading price is -67.60% away from its 52-week high, while its distance from the 52-week low is 28.68%. The stock’s
In terms of market performance, Lineage Cell Therapeutics Inc had a fairly uneven. The highest value for the stock in the past year was $1.56 on 04/04/24, and the lowest value was recorded at $0.45 on 04/01/25. 52-week price history of LCTX Stock A stock’s
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 1.41%. However, over the past six months, we’ve seen a stronger performance of -42.09%. The
Lineage Cell Therapeutics Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $1.61 on 03/28/24, while the lowest price for the same duration was marked at $0.48 on 12/30/24. 52-week price history of LCTX
A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Lineage Cell Therapeutics Inc’s current trading price is -64.32% away from its 52-week high, while its distance from the 52-week low is 19.42%. The
All rights reserved © 2024, Powered By Smart TechOne
